Literature DB >> 24715285

DNA vaccination in skin enhanced by electroporation.

Kate E Broderick1, Amir S Khan, Niranjan Y Sardesai.   

Abstract

DNA vaccines are a next generation branch of vaccines which offer major benefits over their conventional counterparts. However, to be effective in large mammals and humans, an enhancing delivery technology is required. Electroporation is a physical technique which results in improved delivery of large molecules through the cell membrane. In the case of plasmid DNA, electroporation enhances both the uptake and expression of the delivered DNA. The skin is an attractive tissue for DNA vaccination in a clinical setting due to the accessibility of the target, the ease of monitoring, and most importantly the immunocompetent nature of the dermis. Electroporation in the skin has the benefit of being minimally invasive and generally well tolerated. Previous studies have determined that optimized electroporation parameters (such as electrical field intensity, pulse length, pulse width, and plasmid formulation) majorly impact the efficiency of DNA delivery to the skin. We provide an overview of DNA vaccination in skin and muscle. In addition, we detail a protocol for the successful intradermal electroporation of plasmid DNA to guinea pig skin, an excellent dermatological animal model. The work detailed here suggests that the technique is safe and effective and could be highly applicable to a clinical setting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24715285     DOI: 10.1007/978-1-4939-0410-5_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Robust antibody and cellular responses induced by DNA-only vaccination for HIV.

Authors:  Stephen C De Rosa; Srilatha Edupuganti; Yunda Huang; Xue Han; Marnie Elizaga; Edith Swann; Laura Polakowski; Spyros A Kalams; Michael C Keefer; Janine Maenza; Yiwen Lu; Megan C Wise; Jian Yan; Matthew P Morrow; Amir S Khan; Jean D Boyer; Laurent Humeau; Scott White; Michael Pensiero; Niranjan Y Sardesai; Mark L Bagarazzi; David B Weiner; Guido Ferrari; Georgia D Tomaras; David C Montefiori; Lawrence Corey; M Juliana McElrath
Journal:  JCI Insight       Date:  2020-07-09

2.  DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.

Authors:  Kathleen A Cashman; Eric R Wilkinson; Suzanne E Wollen; Joshua D Shamblin; Justine M Zelko; Jeremy J Bearss; Xiankun Zeng; Kate E Broderick; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2017-11-14       Impact factor: 3.452

3.  A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever.

Authors:  Kathleen A Cashman; Eric R Wilkinson; Carl I Shaia; Paul R Facemire; Todd M Bell; Jeremy J Bearss; Joshua D Shamblin; Suzanne E Wollen; Kate E Broderick; Niranjan Y Sardesai; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2017-10-18       Impact factor: 3.452

4.  Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma.

Authors:  Spela Kos; Alessandra Lopes; Veronique Preat; Maja Cemazar; Ursa Lampreht Tratar; Bernard Ucakar; Kevin Vanvarenberg; Gregor Sersa; Gaelle Vandermeulen
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

5.  Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.

Authors:  Alessia Lamolinara; Lorenzo Stramucci; Albana Hysi; Manuela Iezzi; Cristina Marchini; Marianna Mariotti; Augusto Amici; Claudia Curcio
Journal:  J Immunol Res       Date:  2015-07-13       Impact factor: 4.818

Review 6.  Perspectives on Transdermal Electroporation.

Authors:  Kevin Ita
Journal:  Pharmaceutics       Date:  2016-03-17       Impact factor: 6.321

7.  Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus.

Authors:  Karuppiah Muthumani; Peter Block; Seleeke Flingai; Nagarajan Muruganantham; Itta Krishna Chaaithanya; Colleen Tingey; Megan Wise; Emma L Reuschel; Christopher Chung; Abirami Muthumani; Gopalsamy Sarangan; Padma Srikanth; Amir S Khan; Paluru Vijayachari; Niranjan Y Sardesai; J Joseph Kim; Kenneth E Ugen; David B Weiner
Journal:  J Infect Dis       Date:  2016-03-21       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.